Bivalirudin
XJTU1AF2024LSYY-321
Unknown small_molecule active
Quick answer
Bivalirudin for ST-segment Elevation Myocardial Infarction (STEMI) is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- ST-segment Elevation Myocardial Infarction (STEMI)
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active